122 related articles for article (PubMed ID: 25966097)
1. Expression and significance of SATB1 in the development of breast cancer.
Zhang S; Gao X; Ma Y; Jiang J; Dai Z; Yin X; Min W; Hui W; Wang B
Genet Mol Res; 2015 Apr; 14(2):3309-17. PubMed ID: 25966097
[TBL] [Abstract][Full Text] [Related]
2. Expression of SATB1 protein in the ductal breast carcinoma tissue microarrays - preliminary study.
Kobierzycki C; Wojnar A; Dziegiel P
Folia Histochem Cytobiol; 2013; 51(4):333-8. PubMed ID: 24497139
[TBL] [Abstract][Full Text] [Related]
3. Is SATB1 a master regulator in breast cancer growth and metastasis?
Zheng J
Womens Health (Lond); 2008 Jul; 4(4):329-32. PubMed ID: 19072498
[TBL] [Abstract][Full Text] [Related]
4. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
[TBL] [Abstract][Full Text] [Related]
5. Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinoma.
Laurinavicius A; Green AR; Laurinaviciene A; Smailyte G; Ostapenko V; Meskauskas R; Ellis IO
Oncotarget; 2015 Dec; 6(38):41134-45. PubMed ID: 26512778
[TBL] [Abstract][Full Text] [Related]
6. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.
Han HJ; Russo J; Kohwi Y; Kohwi-Shigematsu T
Nature; 2008 Mar; 452(7184):187-93. PubMed ID: 18337816
[TBL] [Abstract][Full Text] [Related]
7. SATB1 is Correlated with Progression and Metastasis of Breast Cancers: A Meta-Analysis.
Pan Z; Jing W; He K; Zhang L; Long X
Cell Physiol Biochem; 2016; 38(5):1975-83. PubMed ID: 27161300
[TBL] [Abstract][Full Text] [Related]
8. Expression of SATB1, MTI/II and Ki-67 in Mycosis Fungoides.
Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Bieniek A; Dziegiel P
Anticancer Res; 2016 Jan; 36(1):189-97. PubMed ID: 26722043
[TBL] [Abstract][Full Text] [Related]
9. [Expression of special AT-rich sequence-binding protein mRNA and its clinicopathological significance in non-small cell lung cancer].
Zhou LY; Liu F; Tong J; Chen QQ; Zhang FW
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):534-7. PubMed ID: 19304547
[TBL] [Abstract][Full Text] [Related]
10. SATB1 gene expression and breast cancer prognosis.
Hanker LC; Karn T; Mavrova-Risteska L; Ruckhäberle E; Gaetje R; Holtrich U; Kaufmann M; Rody A; Wiegratz I
Breast; 2011 Aug; 20(4):309-13. PubMed ID: 20980149
[TBL] [Abstract][Full Text] [Related]
11. Expression of p16 and SATB1 in Invasive Ductal Breast Cancer - A Preliminary Study.
Kobierzycki C; Grzegrzolka J; Glatzel-Plucinska N; Piotrowska A; Wojnar A; Smolarz B; Romanowicz H; Dziegiel P
In Vivo; 2018; 32(4):731-736. PubMed ID: 29936452
[TBL] [Abstract][Full Text] [Related]
12. [Expression of special AT-rich sequence-binding protein in bladder urothelial carcinoma and its clinical significance].
Liu CX; Wen Y; Xu K; Zheng SB; Xu YW; Chen BS
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1389-91, 1394. PubMed ID: 20584685
[TBL] [Abstract][Full Text] [Related]
13. Special AT-rich sequence-binding protein-1 participates in the maintenance of breast cancer stem cells through regulation of the Notch signaling pathway and expression of Snail1 and Twist1.
Sun Z; Zhang C; Zou X; Jiang G; Xu Z; Li W; Xie H
Mol Med Rep; 2015 May; 11(5):3235-542. PubMed ID: 25586771
[TBL] [Abstract][Full Text] [Related]
14. Decoy-DNA against special AT-rich sequence binding protein 1 inhibits the growth and invasive ability of human breast cancer.
Yamayoshi A; Yasuhara M; Galande S; Kobori A; Murakami A
Oligonucleotides; 2011; 21(2):115-21. PubMed ID: 21500976
[TBL] [Abstract][Full Text] [Related]
15. Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer.
Baba H; Ishikawa T; Mogushi K; Ishiguro M; Uetake H; Tanaka H; Sugihara K
Anticancer Res; 2016 Aug; 36(8):4069-76. PubMed ID: 27466515
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma.
Chen H; Takahara M; Oba J; Xie L; Chiba T; Takeuchi S; Tu Y; Nakahara T; Uchi H; Moroi Y; Furue M
J Dermatol Sci; 2011 Oct; 64(1):39-44. PubMed ID: 21767935
[TBL] [Abstract][Full Text] [Related]
17. [Expression of SATB1 and BRMS1 in ovarian serous adenocarcinoma and its relationship with clinieopathological features].
Zhao XL; Wang P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):82-5, 105. PubMed ID: 21355308
[TBL] [Abstract][Full Text] [Related]
18. [Expression of special AT-rich sequence-binding protein 1 mRNA in hepatocellular carcinoma and its clinical significance].
Peng ZK; Yang DH; Li XH; Huang Y; Zhang GQ; Zhong KB; Bi MP; Li GH
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1207-11. PubMed ID: 21764697
[TBL] [Abstract][Full Text] [Related]
19. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis].
Zhang B; Liu FF; Ma YJ; Gu F
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):904-9. PubMed ID: 24506959
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of SATB1 in laryngeal squamous cell carcinoma.
Zhao XD; Ji WY; Zhang W; He LX; Yang J; Liang HJ; Wang LL
ORL J Otorhinolaryngol Relat Spec; 2010; 72(1):1-5. PubMed ID: 20110741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
